CW May 2000
Volume 9Issue Number 5 May 2000 ISSN 10593802 Comparison of Chemotherapy Dose for Metastatic Breast CancerFor metastatic breast cancer patients, high-dose chemotherapy together with stem-cell transplantation does not improve overall survival rate compared to conventional-dose chemotherapy. Additionally, patients treated with aggressive therapy experience severe adverse side effects.
Go to Previous Page Go to Next Page Source & Additional Reading The New England Journal of Medicine, April 13, 2000. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW May 2000Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
